Schedule 13D ownership disclosure

Century Therapeutics, Inc.

Security class unavailable · CUSIP: 15673T100

Event date: 2022-10-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,206,380
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-22-005902
Form type
SC 13D/A
Filer
Casdin Capital, LLC
CIK
CIK 1534261
Filed
Oct 11, 2022
Reporting period
Oct 01, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub